No Data
No Data
No Data
No Data
No Data
Cyclerion Therapeutics Announced That Regina Graul Has Joined The Company As President, Effective Immediately, Peter Hecht Will Continue To Work As A Strategic Consultant And Board Member; Steps Down From CEO Role
Cyclerion Therapeutics Announced That Regina Graul Has Joined The Company As President, Effective Immediately, Peter Hecht Will Continue To Work As A Strategic Consultant And Board Member; Steps Down
BenzingaDec 4, 2023 21:11
Cyclerion Therapeutics Names Regina Graul President >CYCN
Cyclerion Therapeutics Names Regina Graul President >CYCN
Dow JonesDec 4, 2023 21:03
Press Release: Cyclerion Appoints Regina Graul, Ph.D., as President
Cyclerion Appoints Regina Graul, Ph.D., as President -- Dr. Graul will lead the rebuild of Cyclerion, bringing more than two decades of drug making experience, R&D portfolio leadership, and a deep ex
Dow JonesDec 4, 2023 21:00
12 Health Care Stocks Moving In Friday's Intraday Session
GainersNexImmune (NASDAQ:NEXI) stock moved upwards by 540.4% to $11.07 during Friday's regular session. The market value of their outstanding shares is at $11.7 million. Generation Bio (NASDAQ:GBIO) s
BenzingaDec 2, 2023 01:31
Cyclerion Therapeutics: Announces Appointments of Dina Katabi, Ph.D., and Michael Higgins to Bd of Directors >CYCN
Cyclerion Therapeutics: Announces Appointments of Dina Katabi, Ph.D., and Michael Higgins to Bd of Directors >CYCN
Dow JonesDec 1, 2023 07:19
Press Release: Cyclerion Strengthens Board of Directors With Experienced Company Builder and Cutting-edge Innovator
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator - Dina Katabi, Ph.D.: World leader in healthcare AI applications at MIT; inventor of groundbreakin
Dow JonesDec 1, 2023 07:16
No Data
No Data